Valtrex and Cytomegalovirus infection - a phase IV clinical study of FDA data
Summary:
Cytomegalovirus infection is found among people who take Valtrex, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Valtrex and have Cytomegalovirus infection. It is created by eHealthMe based on reports of 32,398 people who have side effects when taking Valtrex from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
32,398 people reported to have side effects when taking Valtrex.
Among them, 108 people (0.33%) have Cytomegalovirus infection.
What is Valtrex?
Valtrex has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. eHealthMe is studying from 34,253 Valtrex users for its effectiveness, alternative drugs and more.
What is Cytomegalovirus infection?
Cytomegalovirus infection is found to be associated with 1,232 drugs and 951 conditions by eHealthMe.
Number of Valtrex and Cytomegalovirus infection reports submitted per year:
Time on Valtrex when people have Cytomegalovirus infection *:
Gender of people who have Cytomegalovirus infection when taking Valtrex*:
Age of people who have Cytomegalovirus infection when taking Valtrex *:
Common drugs people take besides Valtrex *:
Common side effects people have besides Cytomegalovirus infection *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Valtrex and have Cytomegalovirus infection?
Check whether Cytomegalovirus infection is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of Valtrex:
- Valtrex (34,253 reports)
Cytomegalovirus infection treatments and more:
- Cytomegalovirus infection (20,015 reports)
COVID vaccines that are related to Cytomegalovirus infection:
- Cytomegalovirus infection in Moderna COVID Vaccine
- Cytomegalovirus infection in Pfizer BioNTech Covid Vaccine
- Cytomegalovirus infection in Johnson and Johnson Covid Vaccine
How severe was Cytomegalovirus infection and when was it recovered:
Expand to all the drugs that have ingredients of valacyclovir hydrochloride:
Common drugs associated with Cytomegalovirus infection:
- Acetaminophen: 151 reports
- Acyclovir: 440 reports
- Allopurinol: 339 reports
- Amlodipine: 286 reports
- Amphotericin b: 197 reports
- Aspirin: 253 reports
- Atenolol: 134 reports
- Azathioprine: 809 reports
- Bactrim: 594 reports
- Bendamustine hydrochloride: 164 reports
- Bortezomib: 123 reports
- Budesonide: 111 reports
- Busulfan: 805 reports
- Busulfex: 141 reports
- Campath: 310 reports
- Carboplatin: 122 reports
- Ceftazidime: 106 reports
- Cellcept: 842 reports
- Ciclosporin: 192 reports
- Cisplatin: 173 reports
- Cotrim: 170 reports
- Cyclophosphamide: 2,166 reports
- Cyclosporine: 1,878 reports
- Cytarabine: 492 reports
- Dexamethasone: 323 reports
- Diflucan: 174 reports
- Enbrel: 131 reports
- Epivir: 113 reports
- Etoposide: 492 reports
- Famotidine: 206 reports
- Fluconazole: 576 reports
- Fludara: 1,716 reports
- Fludarabine phosphate: 546 reports
- Folic acid: 104 reports
- Foscavir: 114 reports
- Furosemide: 375 reports
- Ganciclovir: 549 reports
- Ganciclovir sodium: 124 reports
- Heparin: 196 reports
- Humira: 201 reports
- Imuran: 159 reports
- Insulin: 103 reports
- Isoniazid: 117 reports
- Itraconazole: 167 reports
- Lansoprazole: 213 reports
- Lasix: 249 reports
- Levofloxacin: 104 reports
- Lipitor: 111 reports
- Lopurin: 331 reports
- Magnesium: 128 reports
- Medrol: 217 reports
- Melphalan: 300 reports
- Mercaptopurine: 109 reports
- Meropenem: 209 reports
- Methotrexate: 1,484 reports
- Methotrexate sodium: 131 reports
- Methylprednisolone: 737 reports
- Methylprednisolone sodium succinate: 241 reports
- Metronidazole: 139 reports
- Morphine: 147 reports
- Mycophenolate mofetil: 3,461 reports
- Mycophenolic acid: 451 reports
- Myfortic: 271 reports
- Neoral: 760 reports
- Nexium: 135 reports
- Nifedipine: 115 reports
- Norvasc: 187 reports
- Nystatin: 195 reports
- Omeprazole: 465 reports
- Ondansetron: 101 reports
- Pantoprazole: 290 reports
- Paracetamol: 138 reports
- Pentam: 113 reports
- Prednisolone: 2,704 reports
- Prednisone: 2,551 reports
- Prograf: 1,065 reports
- Rabeprazole: 106 reports
- Ranitidine: 175 reports
- Rapamune: 176 reports
- Remicade: 686 reports
- Revlimid: 115 reports
- Rituxan: 193 reports
- Sandimmune: 239 reports
- Simulect: 259 reports
- Sirolimus: 233 reports
- Sodium bicarbonate: 110 reports
- Soliris: 141 reports
- Solu-medrol: 319 reports
- Sulfamethoxazole: 112 reports
- Sulfamethoxazole and trimethoprim: 257 reports
- Tacrolimus: 2,935 reports
- Thiotepa: 453 reports
- Tylenol: 103 reports
- Ursodeoxycholic acid: 118 reports
- Valacyclovir: 137 reports
- Valcyte: 431 reports
- Valganciclovir hydrochloride: 158 reports
- Valtrex: 108 reports
- Velcade: 284 reports
- Vincristine sulfate: 159 reports
- Voriconazole: 153 reports
- Zantac: 102 reports
- Zovirax: 112 reports
All the drugs that are associated with Cytomegalovirus infection:
- Cytomegalovirus infection (1,232 drugs)
Common conditions associated with Cytomegalovirus infection:
- Acute graft versus host disease: 142 reports
- Acute lymphocytic leukemia (all): 224 reports
- Acute myeloid leukaemia: 133 reports
- Acute myeloid leukaemia aggravated: 130 reports
- Aplastic anaemia: 131 reports
- Aplastic anemia: 131 reports
- B-cell lymphoma: 245 reports
- Blood pressure increased: 453 reports
- Bone marrow conditioning regimen: 883 reports
- Burkitt lymphoma: 244 reports
- Cancer - acute childhood leukemia (all): 237 reports
- Chronic lymphocytic leukaemia: 282 reports
- Colitis ulcerative: 588 reports
- Constipation: 124 reports
- Crohn's disease: 384 reports
- Crohns disease: 384 reports
- Cytomegalovirus infection: 303 reports
- Diffuse large b-cell lymphoma: 276 reports
- Disseminated lupus erythematosus: 126 reports
- Gastritis: 106 reports
- Graft versus host disease: 298 reports
- Hbp: 453 reports
- Hepatic transplant: 342 reports
- High blood pressure: 453 reports
- Hiv: 286 reports
- Hiv antibody positive: 286 reports
- Hiv infection: 313 reports
- Human immunodeficiency virus infection: 303 reports
- Hypertension: 472 reports
- Ileitis: 384 reports
- Immunodeficiency disorders: 1,008 reports
- Immunosuppression: 1,009 reports
- Inability to sleep: 119 reports
- Infection: 558 reports
- Inflammatory bowel disease - crohn's disease: 403 reports
- Insomnia: 119 reports
- Kidney transplant: 1,398 reports
- Liver transplant: 327 reports
- Lymphoma - non-hodgkin's: 276 reports
- Multiple myeloma: 478 reports
- Multiple sclerosis: 135 reports
- Non-hodgkin's lymphoma: 293 reports
- Osteoporosis: 139 reports
- Plasma cell myeloma: 422 reports
- Preventive health care: 621 reports
- Regional enteritis: 403 reports
- Renal transplant: 1,398 reports
- Rheumatoid arthritis: 400 reports
- Small non-cleaved cell lymphoma: 244 reports
- Stem cell transplant: 672 reports
- Systemic lupus erythematosus: 126 reports
- Thrombosis: 118 reports
- Transplant - kidney: 1,441 reports
- Transplant - liver: 327 reports
- Ulcerative colitis: 553 reports
All the conditions that are associated with Cytomegalovirus infection:
- Cytomegalovirus infection (951 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on valacyclovir hydrochloride (the active ingredients of Valtrex) and Valtrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Avandamet and Skin Exfoliation - 13 seconds ago
- Cellcept and Axillary Mass - 13 seconds ago
- Tuberculosis and Fainting - 25 seconds ago
- Percutaneous Coronary Intervention and Blood Creatine Phosphokinase Mb Increased - 33 seconds ago
- Everolimus and Renal Cyst - 57 seconds ago